Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ERAS
ERAS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ERAS ETF News Today | Earnings, Events & Price Alerts
ERAS News
FDA's Accelerated Approval Framework Drives Cancer Treatment Advances
Feb 17 2026
Newsfilter
Erasca Stock Declines Without News Justification
Jan 26 2026
Benzinga
Intuitive Surgical (ISRG) Reports Q4 Revenue of $2.87 Billion, Exceeding Expectations
Jan 24 2026
Benzinga
Erasca, Inc. Closes $258.8 Million Upsized Public Offering
Jan 23 2026
Newsfilter
Namib Minerals Stock Soars 334% with RSI at 92.4, Warning for Investors
Jan 23 2026
Benzinga
RF Industries and Ultra Clean Holdings Surge, RSI Overbought Warning
Jan 22 2026
Benzinga
Erasca (ERAS) Prices Upsized Public Offering of 22.5M Shares at $10.00 Each, Raising $225M
Jan 22 2026
seekingalpha
Erasca Inc. Prices Upsized Public Offering at $10 per Share, Raising $225 Million
Jan 22 2026
Globenewswire
Erasca Inc. Prices Upsized Public Offering of $225 Million in Common Stock
Jan 22 2026
Newsfilter
Erasca, Inc. Prices Upsized Public Offering at $10.00 per Share for $225 Million
Jan 22 2026
Yahoo Finance
Tigo Energy (TYGO) Pays Off $50M Convertible Note, Stock Soars 126%
Jan 21 2026
Benzinga
Netflix Reports Q4 Results, Q1 Guidance Misses Estimates
Jan 21 2026
Benzinga
Erasca Inc. (ERAS) Plans $150 Million Public Offering Amid 4.18% Stock Drop
Jan 21 2026
NASDAQ.COM
Erasca Inc (ERAS) Proposes $150 Million Public Offering, Shares Drop 8.1%
Jan 20 2026
Benzinga
Erasca (ERAS) Announces $150M Public Offering to Fund Cancer Research
Jan 20 2026
seekingalpha
Health Care Stocks Warning: VERO RSI at 95.9 Indicates Overbought
Jan 20 2026
Benzinga
Show More News
